Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Brukinsa receives approval in China for patients with CLL/SLL and MCL

June 4, 2020

FDA accepts IND for phase I/II trial of Treadwell's HPK1 inhibitor CFI-402411

June 4, 2020

Ovarian organoids implicate oviducts

June 4, 2020

Efficacy and safety reported for alflutinib in NSCLC patients with EGFR T790M mutation

June 3, 2020

Beijing Reciproca Pharmaceuticals identifies new Bruton tyrosine kinase inhibitors

June 3, 2020

New PI3K-gamma inhibitors disclosed by Incyte

June 3, 2020

Bayer patents cytostatic conjugates with integrin alphavbeta3 ligands

June 3, 2020

Preliminary safety data reported from ILLUMINATE-206 study

June 3, 2020

Nimbus Artemis describes new ATP-citrate synthase inhibitors

June 3, 2020

Maximum tolerated dose identified with positive safety profile for CC-92480 in multiple myeloma

June 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...